Clinical trials: Simvastatin Multiple Sclerosis

Relapsing Remitting Multiple Sclerosis

Simvastatin in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Using Avonex Compared to Placebo

• Completed
• Age: 15 to 60 years
• Phase 3

Patient with relapsing remitting multiple sclerosis taking avonex are included in this double blind randomized control trial. Simvastatin is compared to placebo.

Trial name

irmsrct (NCT00668343)

Testing

simvastatin

Where

Iran

Volunteers

80 people

Sponsor

Tehran University of Medical Sciences